End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
115,800 KRW | +1.31% |
|
+1.05% | -7.73% |
06-10 | FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A | CI |
05-20 | Gc Biopharma and Novel Pharma Announce Sanfilippo Syndrome Treatment Obtains FDA IND Approval | CI |
- Stock Market
- Equities
- A006280 Stock
- News GC Biopharma Corp.